Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.
Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.
Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.
Requires certain manufacturers of prescription drugs to notify the superintendent of any proposed increase of the wholesale acquisition cost of such prescription drugs.
Requires certain manufacturers of prescription drugs to notify the superintendent of any proposed increase of the wholesale acquisition cost of such prescription drugs.
Requires prescription containers for opioid medications to have a red cap top and a printed warning about the risks of overdose and addiction.
Requires prescription containers for opioid medications to have a red cap top and a printed warning about the risks of overdose and addiction.
Requires pharmacists to include lot numbers or unique identifying numbers on prescription containers.
Enacts the "foreign drug transparency act"; requires the disclosure to a health plan, pharmacy and patient whether a prescription drug was manufactured or compounded in a foreign country; whether the prescription was approved by the federal food and drug administration foreign drug inspection program; requires the date of the last inspection of such prescription drug by the federal food and drug administration foreign drug inspection program; requires certain labelling on such drugs.
Permits prescription labels for medication abortion prescription drugs to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.